Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2009 Apr;90(2):156–165. doi: 10.1111/j.1365-2613.2008.00624.x

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Journal compilation © 2009 Blackwell Publishing Ltd

PMC Copyright notice

(a) Ventral lobe of the prostate. α-DG immunolocalization from the control group: strong α-DG immunoreactivity (arrows) in the secretory epithelium (EP) and smooth muscle cells. Stroma (St). Lumen (L). (b) Ventral lobe of the prostate. β-DG immunolocalization from the control group: strong β-DG immunoreactivity (arrows) in the periacinal prostatic stroma. Epithelium (EP). Stroma (St). Lumen (L). (c) Ventral lobe of the prostate. α-DG immunolocalization from the diabetic group: weak α-DG immunoreactivity (arrows) in the secretory epithelium (EP) and smooth muscle cells. Stroma (St). Lumen (L). (d) Ventral lobe of the prostate. β-DG immunolocalization from the diabetic group: weak β-DG immunoreactivity (arrows) in the periacinal prostatic stroma. Secretory epithelium (EP). Stroma (St). Lumen (L). (e) Ventral lobe of the prostate. α-DG immunolocalization from the diabetic-insulin group: Moderate α-DG immunoreactivity (arrows) in the secretory epithelium (EP) and smooth muscle cells. Stroma (St). Lumen (L). (f) Ventral lobe of the prostate. β-DG immunolocalization from the diabetic-insulin group: Moderate β-DG immunoreactivity (arrows) in the periacinal prostatic stroma. Secretory epithelium (EP). Stroma (St). Lumen (L).